Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2657)
All Articles published online
|
Apr 14, 2007 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu BY, Guo LP, Lee SS, Dong QM, Tan Y, Yao H, Li LH, Lin CK, Kung HF, He ML. Genetic variability of CYP2B6 polymorphisms in four southern Chinese populations. World J Gastroenterol 2007; 13(14): 2100-2103 [PMID: 17465455 DOI: 10.3748/wjg.v13.i14.2100] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i14/2100.htm |
| Number | Citing Articles |
| 1 |
Jing Li, Vincent Menard, Rebekah L Benish, Richard J Jurevic, Chantal Guillemette, Mark Stoneking, Peter A Zimmerman, Rajeev K Mehlotra.
Worldwide Variation in Human Drug-Metabolism Enzyme Genes
CYP2B6
and
UGT2B7
: Implications for HIV/AIDS Treatment
. Pharmacogenomics 2012; 13(5): 555 doi: 10.2217/pgs.11.160
|
| 2 |
Gianluca Russo, Giacomo Maria Paganotti, Sandra Soeria-Atmadja, Miriam Haverkamp, Doreen Ramogola-Masire, Vincenzo Vullo, Lars Lennart Gustafsson. Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments. Infection, Genetics and Evolution 2016; 37: 192 doi: 10.1016/j.meegid.2015.11.014
|
| 3 |
Shui Shan Lee, Kin Wang To, Man Po Lee, Ngai Sze Wong, Denise PC Chan, Patrick CK Li, Siu Wai Cheung, Raphael CY Chan. Sleep quality in efavirenz-treated Chinese HIV patients – comparing between GT and GG genotype of CYP2B6-516 G/T polymorphisms. International Journal of STD & AIDS 2014; 25(3): 193 doi: 10.1177/0956462413498581
|
| 4 |
Li‐Li Yu, Wei Zhang, Juan Li, Li Zhao. Association between CYP2B6 polymorphism and acute leukemia in a Han population of Northwest China. Molecular Genetics & Genomic Medicine 2020; 8(5) doi: 10.1002/mgg3.1162
|
| 5 |
Zhimi Tan, Xiaofang Jia, Fang Ma, Yanling Feng, Hongzhou Lu, Jun-O Jin, Dage Wu, Lin Yin, Li Liu, Lijun Zhang, Anil Kumar. Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz. PLOS ONE 2017; 12(11): e0188366 doi: 10.1371/journal.pone.0188366
|
| 6 |
Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 2009; 41(2): 89 doi: 10.1080/03602530902843483
|
| 7 |
Izaskun Arenaz, Jorge Vicente, Ana Fanlo, Patricia Vásquez, Juan Carlos Medina, Blanca Conde, Fabricio González‐Andrade, Blanca Sinués. Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans. Fundamental & Clinical Pharmacology 2010; 24(2): 247 doi: 10.1111/j.1472-8206.2009.00753.x
|
| 8 |
Jun Chen, Jianjun Sun, Qing Ma, Yaming Yao, Zhenyan Wang, Lijun Zhang, Li Li, Fuyan Sun, Hongzhou Lu. CYP2B6 Polymorphism and Nonnucleoside Reverse Transcriptase Inhibitor Plasma Concentrations in Chinese HIV-Infected Patients. Therapeutic Drug Monitoring 2010; 32(5): 573 doi: 10.1097/FTD.0b013e3181ea953c
|
| 9 |
Zhong-hai Yuan, Qian Liu, Ying Zhang, Hong-xing Liu, Jun Zhao, Ping Zhu. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility. Annals of Hematology 2011; 90(3): 293 doi: 10.1007/s00277-010-1085-z
|
| 10 |
Michael S. Abers, Wayne X. Shandera, Joseph S. Kass. Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs. CNS Drugs 2014; 28(2): 131 doi: 10.1007/s40263-013-0132-4
|
| 11 |
Tai Ning Lam, Ka Ho Hui, Denise Pui Chung Chan, Shui Shan Lee. Genotype-guided dose adjustment for the use of efavirenz in HIV treatment. Journal of Infection 2015; 71(5): 607 doi: 10.1016/j.jinf.2015.07.005
|
| 12 |
Dong Guo, Zhirong Tan, Xiaoya Lou, Shan Shi, Yan Shu, Honghao Zhou, Li Yu, Hong Yang. A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients. European Journal of Clinical Pharmacology 2022; 78(4): 565 doi: 10.1007/s00228-021-03227-5
|
| 13 |
|
| 14 |
Caroline Solas, Marie-Claude Gagnieu. Niveau de preuve du suivi thérapeutique pharmacologique de l’efavirenz. Therapies 2011; 66(3): 197 doi: 10.2515/therapie/2011033
|
| 15 |
Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen, John A. Schetz, Charles P. France. Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs. Pharmacological Reviews 2018; 70(3): 684 doi: 10.1124/pr.117.013706
|
| 16 |
Mei Tan, Megan Bowers, Phil Thuma, Elena L. Grigorenko. The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long‐Term ARV Treatment. New Directions for Child and Adolescent Development 2020; 2020(171): 107 doi: 10.1002/cad.20353
|
| 17 |
HariOm Singh, Sonam Lata, T. N. Dhole, Raman R. Gangakhedkar. Occurrence of CYP2B6 516G>T polymorphism in patients with ARV‐associated hepatotoxicity. Molecular Genetics & Genomic Medicine 2019; 7(4) doi: 10.1002/mgg3.598
|
| 18 |
Eunsol Yang, Jung Sunwoo, Ki Young Huh, Yu Kyong Kim, SeungHwan Lee, In‐Jin Jang, Kyung‐Sang Yu. Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese. Clinical and Translational Science 2022; 15(2): 490 doi: 10.1111/cts.13167
|
| 19 |
Li Zhang, Xianmin Meng, Ping Dong, Tangkai Qi, Li Liu, Bin Wang. Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis. International Journal of STD & AIDS 2023; 34(1): 37 doi: 10.1177/09564624221134137
|
| 20 |
Guo-Fu Li, Guo Yu, Hong-Xia Liu, Qing-Shan Zheng. Ethnic-Specific In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Approaches to Predict Cytochrome P450-Mediated Pharmacokinetics in the Chinese Population: Opportunities and Challenges. Clinical Pharmacokinetics 2014; 53(2): 197 doi: 10.1007/s40262-013-0119-9
|
| 21 |
J Sun, J Chen, Y Yao, R Zhang, Y Zheng, L Liu, L Zhang, Y Shen, H Lu. Minimum effective plasma concentration of efavirenz in treatment-naïve Chinese HIV-infected patients. International Journal of STD & AIDS 2010; 21(12): 810 doi: 10.1258/ijsa.2010.010114
|
| 22 |
Kin Wang To, Shui Teng Liu, Siu Wai Cheung, D Pui Chung Chan, R Chiu Yeung Chan, Shui Shan Lee. Pharmacokinetics of Plasma Efavirenz and CYP2B6 Polymorphism in Southern Chinese. Therapeutic Drug Monitoring 2009; 31(4): 527 doi: 10.1097/FTD.0b013e3181ad74a4
|
| 23 |
Patrice Muret, Sarah Piedoux, Caroline Solas, Sylvie Quaranta. Niveau de preuve du suivi therapeutique pharmacologique de la névirapine. Therapies 2011; 66(3): 187 doi: 10.2515/therapie/2011030
|
| 24 |
N Musa, MI Zulkafli, N Talib, N Mohamad, H Fauzi, R Ismail. Haplotypes frequencies of CYP2B6 in Malaysia. Journal of Postgraduate Medicine 2012; 58(4): 235 doi: 10.4103/0022-3859.105439
|
| 25 |
S. Chantarangsu, T. R. Cressey, S. Mahasirimongkol, E. Capparelli, Y. Tawon, N. Ngo-Giang-Huong, G. Jourdain, M. Lallemant, W. Chantratita. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women. Journal of Antimicrobial Chemotherapy 2009; 64(6): 1265 doi: 10.1093/jac/dkp351
|
| 26 |
Xia Liu, Qing Ma, Yan Zhao, Weiwei Mu, Xin Sun, Yuewu Cheng, Huiping Zhang, Ye Ma, Fujie Zhang. Impact of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz and Lopinavir/Ritonavir in Chinese Children Infected with the Human Immunodeficiency Virus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2017; 37(9): 1073 doi: 10.1002/phar.1988
|
| 27 |
Joseph McGraw, Donald Waller. Cytochrome P450 variations in different ethnic populations. Expert Opinion on Drug Metabolism & Toxicology 2012; 8(3): 371 doi: 10.1517/17425255.2012.657626
|
| 28 |
M. I. Veiga, S. Asimus, P. E. Ferreira, J. P. Martins, I. Cavaco, V. Ribeiro, T. N. Hai, M. G. Petzold, A. Björkman, M. Ashton, J. P. Gil. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. European Journal of Clinical Pharmacology 2009; 65(4): 355 doi: 10.1007/s00228-008-0573-8
|
| 29 |
KH Hui, SS Lee, TN Lam. Dose Optimization of Efavirenz Based on Individual CYP2B6 Polymorphisms in Chinese Patients Positive for HIV. CPT: Pharmacometrics & Systems Pharmacology 2016; 5(4): 182 doi: 10.1002/psp4.12067
|
| 30 |
AWC Lin, W-C Yam, H-Y Lam, S To, D Chan, KCW Chan, S-S Lee. Pharmacogenetic screening: HLA-B*5701 vs. CYP2B6 G516T. HIV Medicine 2011; 12(4): 255 doi: 10.1111/j.1468-1293.2010.00870.x
|
| 31 |
Tristan Lindfelt, John O'Brien, Jessica C Song, Rajul Patel, Dean L Winslow. Efavirenz Plasma Concentrations and Cytochrome 2B6 Polymorphisms. Annals of Pharmacotherapy 2010; 44(10): 1572 doi: 10.1345/aph.1P141
|
| 32 |
Xianmin Meng, Kang Yin, Jiangrong Wang, Ping Dong, Li Liu, Yinzhong Shen, Li Shen, Qing Ma, Hongzhou Lu, Weimin Cai, Weijing He. Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection. PLOS ONE 2015; 10(6): e0130583 doi: 10.1371/journal.pone.0130583
|
| 33 |
Kang Yin, Xianmin Meng, Ping Dong, Tianran Ding, Li Shen, Li Zhang, Renfang Zhang, Weimin Cai, Hongzhou Lu. A simple, rapid, economical, and practical method for the determination of efavirenz in plasma of Chinese AIDS patients by reverse phase high-performance liquid chromatography with ultraviolet detector. BioScience Trends 2014; 8(4): 227 doi: 10.5582/bst.2014.01002
|